FindTrial
Sign In

Does autologous platelet rich plasma help in improvement of vision in patients of retinitis pigmentosa?

Clinical trial to assess the efficacy of autologous platelet rich plasma (PRP) in cases of retinitis pigmentosa

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/10/037501
Enrollment
50
Registered
2021-10-22
Start date
Unknown
Completion date
Unknown
Last updated
2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H355- Hereditary retinal dystrophy

Interventions

Intervention1: suprachoroidal and subtenon injection of autologuous platelet rich plasma(PRP): 0.2ml of autologous platelet rich plasma will be injected in suprachoroidal space taking aseptic precauti

Sponsors

GSVM Medical College
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Retinitis pigmentosa patients having- Visual acuity ranging from reading of ETDRS chart from one meter onwards to patients who will not able to read ETDRS chart but whose visual acuity will range from finger counting close to face to less than 1 meter

Exclusion criteria

Exclusion criteria: 1.Retinitis pigmentosa patients who will have visual acuity ranging from perception of light to hand movement. 2.Diminution of vision not due to retinitis pigmentosa 3. Other retinal diseases like diabetic retinopathy, hypertensive retinopathy etc 4.One eyed patients 5. Patients not giving consent

Design outcomes

Primary

MeasureTime frame
Visual AcuityTimepoint: Pretreatment, 2nd 4th and 6th week—

Secondary

MeasureTime frame
multifocal electro-retinogram (mfERG), ocular coherence tomography (OCT) and perimetry (10-2)Timepoint: Pretreatment and at 6 weeks after first injection—

Countries

India

Contacts

Public ContactDr Kumari Kanchan Kiran

GSVM Medical College

lubnaperwez@gmail.com8400331179

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026